HIV-Associated central nervous system tuberculosis

Seminars in Neurology

Volumn 34, Issue 1, 2014, Pages 103-116

  Chamie, Gabriel ^a   Marquez, Carina ^a   Luetkemeyer, Anne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

central nervous system; human immunodeficiency virus; tuberculosis; tuberculosis meningitis

Indexed keywords

ACETYLSALICYLIC ACID; DEXAMETHASONE; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RALTEGRAVIR; RIFAMPICIN; STREPTOMYCIN;

ABSCESS; ARTICLE; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPATHOGENESIS; INTRACRANIAL TUBERCULOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUBERCULOUS MENINGITIS; CENTRAL NERVOUS SYSTEM; COMPLICATION; MICROBIOLOGY; PATHOLOGY; TUBERCULOSIS;

CENTRAL NERVOUS SYSTEM; HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 84898450499     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0034-1372347     Document Type: Article

References (116)

1. Berenguer J., Moreno S., Laguna F., et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med: 1992; 326 10 668 672
2. Ansari N. A., Kombe A. H., Kenyon T. A., et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis: 2002; 6 1 55 63 (Pubitemid 34263546)
3. Rana F. S., Hawken M. P., Mwachari C., et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr: 2000; 24 1 23 29 (Pubitemid 30447802)
4. Thwaites G. E., Nguyen D. B., Nguyen H. D., et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med: 2004; 351 17 1741 1751
5. Geldmacher C., Zumla A., Hoelscher M. Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS: 2012; 7 3 268 275
6. Kalsdorf B., Scriba T. J., Wood K., et al. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am J Respir Crit Care Med: 2009; 180 12 1262 1270
7. Donald P. R., Schaaf H. S., Schoeman J. F. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect: 2005; 50 3 193 195 (Pubitemid 40361529)
8. Phypers M., Harris T., Power C. CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis: 2006; 10 1 99 103 (Pubitemid 43266285)
9. Yechoor V. K., Shandera W. X., Rodriguez P., Cate T. R. Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med: 1996; 156 15 1710 1716 (Pubitemid 26287128)
10. Swaminathan S., Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis: 2010; 50 3 03 S184 S194
11. Perez-Velez C. M., Marais B. J. Tuberculosis in children. N Engl J Med: 2012; 367 4 348 361
12. Topley J. M., Bamber S., Coovadia H. M., Corr P. D. Tuberculous meningitis and co-infection with HIV. Ann Trop Paediatr: 1998; 18 4 261 266 (Pubitemid 28537597)
13. Marais B. J., Gie R. P., Schaaf H. S., Hesseling A. C., Enarson D. A., Beyers N. The spectrum of disease in children treated for tuberculosis in a highly endemic area. Int J Tuberc Lung Dis: 2006; 10 7 732 738 (Pubitemid 44031385)
14. Dubé M. P., Holtom P. D., Larsen R. A. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med: 1992; 93 5 520 524
15. Thwaites G. E., Duc Bang N., Huy Dung N., et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis: 2005; 192 12 2134 2141 (Pubitemid 41779213)
16. Ho J., Marais B. J., Gilbert G. L., Ralph A. P. Diagnosing tuberculous meningitis - have we made any progress? Trop Med Int Health: 2013; 18 6 783 793
17. Bhagwan S., Naidoo K. Aetiology, clinical presentation, and outcome of meningitis in patients coinfected with human immunodeficiency virus and tuberculosis. AIDS Res Treat: 2011;: 2011; 180352
18. Hosoglu S., Geyik M. F., Balik I., et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis: 2002; 6 1 64 70 (Pubitemid 34263547)
19. Perfect J. R., Dismukes W. E., Dromer F., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis: 2010; 50 3 291 322
20. Jarvis J. N., Percival A., Bauman S., et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-Associated cryptococcal meningitis. Clin Infect Dis: 2011; 53 10 1019 1023
21. Whiteman M., Espinoza L., Post M. J., Bell M. D., Falcone S. Central nervous system tuberculosis in HIV-infected patients: clinical and radiographic findings. AJNR Am J Neuroradiol: 1995; 16 6 1319 1327
22. Gallant J. E., Mueller P. S., McArthur J. C., Chaisson R. E. Intramedullary tuberculoma in a patient with HIV infection. AIDS: 1992; 6 8 889 891
23. Martínez-Vázquez C., Bordón J., Rodríguez- González A., et al. Cerebral tuberculoma-A comparative study in patients with and without HIV infection. Infection: 1995; 23 3 149 153
24. Woolsey R. M., Chambers T. J., Chung H. D., McGarry J. D. Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol: 1988; 45 6 691 693
25. Vidal J. E., Cimerman S., da Silva P. R., Sztajnbok J., Coelho J. F., Lins D. L. Tuberculous brain abscess in a patient with AIDS: case report and literature review. Rev Inst Med Trop Sao Paulo: 2003; 45 2 111 114 (Pubitemid 36565718)
26. Corti M. E., Villafañe M. F., Yampolsky C. G., Schtirbu R. B. Brain abscess due to Mycobacterium tuberculosis in a patient with AIDS: report of a case and review of the literature. Int J Infect Dis: 2005; 9 4 225 227 (Pubitemid 40827164)
27. Vidal J. E., Oliveira A. C., Dauar R. F. Cerebral tuberculomas or tuberculous brain abscess: the dilemma continues. Clin Infect Dis: 2005; 40 7 1072 1073, author reply 1072-1073 (Pubitemid 40418327)
28. Farrar D. J., Flanigan T. P., Gordon N. M., Gold R. L., Rich J. D. Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med: 1997; 102 3 297 301 (Pubitemid 27215607)
29. Vidal J. E., Penalva de Oliveira A. C., Bonasser Filho F., et al. Tuberculous brain abscess in AIDS patients: report of three cases and literature review. Int J Infect Dis: 2005; 9 4 201 207 (Pubitemid 40827161)
30. Thwaites G. E., Chau T. T., Stepniewska K., et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet: 2002; 360 9342 1287 1292 (Pubitemid 35284620)
31. Checkley A. M., Njalale Y., Scarborough M., Zjilstra E. E. Sensitivity and specificity of an index for the diagnosis of TB meningitis in patients in an urban teaching hospital in Malawi. Trop Med Int Health: 2008; 13 8 1042 1046
32. Cecchini D., Ambrosioni J., Brezzo C., et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis: 2009; 13 2 269 271
33. Katrak S. M., Shembalkar P. K., Bijwe S. R., Bhandarkar L. D. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci: 2000; 181 1-2 118 126
34. Vidal J. E., de Oliveira A. C., Hernández A. V. CD4+ T-cell count and cerebrospinal fluid findings in HIV-infected patients with tuberculous meningitis. Int J Tuberc Lung Dis: 2010; 14 11 1496 1497, author reply 1497
35. Laguna F., Adrados M., Ortega A., Gonzalez-Lahoz J. M. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients. AIDS: 1992; 6 10 1165 1167
36. Chen P., Shi M., Feng G. D., et al. A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol: 2012; 50 4 1166 1170
37. Thwaites G. E., Chau T. T., Farrar J. J. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol: 2004; 42 1 378 379 (Pubitemid 38082750)
38. Pai M., Flores L. L., Pai N., Hubbard A., Riley L. W., Colford J. M. Jr. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-Analysis. Lancet Infect Dis: 2003; 3 10 633 643 (Pubitemid 37210227)
39. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland World Health Organization: 2010
40. Horne D. J., Royce S. E., Gooze L., et al. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-Analysis. Lancet Infect Dis: 2010; 10 6 387 394
41. Boehme C. C., Nabeta P., Hillemann D., et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med: 2010; 363 11 1005 1015
42. Tortoli E., Russo C., Piersimoni C., et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J: 2012; 40 2 442 447
43. Vadwai V., Boehme C., Nabeta P., Shetty A., Alland D., Rodrigues C. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol: 2011; 49 7 2540 2545
44. Patel V. B., Theron G., Lenders L., et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med: 2013; 10 10 e1001536
45. Corral I., Quereda C., Navas E., et al. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis. Eur J Clin Microbiol Infect Dis: 2004; 23 6 471 476 (Pubitemid 38901332)
46. Tuon F. F., Higashino H. R., Lopes M. I., et al. Adenosine deaminase and tuberculous meningitis-A systematic review with meta-Analysis. Scand J Infect Dis: 2010; 42 3 198 207
47. van der Merwe D. J., Andronikou S., Van Toorn R., Pienaar M. Brainstem ischemic lesions on MRI in children with tuberculous meningitis: with diffusion weighted confirmation. Childs Nerv Syst: 2009; 25 8 949 954
48. Bernaerts A., Vanhoenacker F. M., Parizel P. M., et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol: 2003; 13 8 1876 1890 (Pubitemid 36949714)
49. Hasbun R., Abrahams J., Jekel J., Quagliarello V. J. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med: 2001; 345 24 1727 1733
50. Prasad K., Singh M. B. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev: 2008; 1 CD002244
51. Schoeman J. F., Janse van Rensburg A., Laubscher J. A., Springer P. The role of aspirin in childhood tuberculous meningitis. J Child Neurol: 2011; 26 8 956 962
52. Misra U. K., Kalita J., Nair P. P. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci: 2010; 293 1-2 12 17
53. Blumberg H. M., Burman W. J., Chaisson R. E., et al. American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med: 2003; 167 4 603 662
54. Cecchini D., Ambrosioni J., Brezzo C., et al. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS: 2007; 21 3 373 374 (Pubitemid 46175052)
55. Thwaites G. E., Lan N. T., Dung N. H., et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis: 2005; 192 1 79 88 (Pubitemid 40863860)
56. Alffenaar J. W., van Altena R., Bökkerink H. J., et al. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis: 2009; 49 7 1080 1082
57. Shandil R. K., Jayaram R., Kaur P., et al. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrob Agents Chemother: 2007; 51 2 576 582 (Pubitemid 46185275)
58. Donald P. R., Seifart H. I. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr: 1989; 115 3 483 486 (Pubitemid 19223196)
59. Ruslami R., Ganiem A. R., Dian S., et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis: 2013; 13 1 27 35
60. Alvarez-Uria G., Midde M., Pakam R., Naik P. K. Initial antituberculous regimen with better drug penetration into cerebrospinal fluid reduces mortality in HIV infected patients with tuberculous meningitis: data from an HIV observational cohort study. Tuberc Res Treat: 2013;, 2013 242604
61. ISRCTN61649292. A randomised, double-blind, placebo-controlled trial to investigate the effect of intensified treatment with high dose rifampicin and levofloxacin for adult patients with tuberculous meningitis. Available at: http://www.controlled-trials.com/ISRCTN61649292. Accessed November 26, 2013
62. Cattamanchi A., Dantes R. B., Metcalfe J. Z., et al. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis: 2009; 48 2 179 185
63. Grinsztejn B., De Castro N., Arnold V., et al. A randomized multicentre open-label trial to estimate the efficacy and safety of two doses of raltegravir (RAL) to efavirenz (EFV) for the treatment of HIV-TB co-infected patients: results of the ANRS 12 180 Reflate TB trial. Paper presented at: 19th International AIDS Conference; June 30-July 3, 2013; Kuala Lumpur, Malaysia
64. Dooley K. E., Sayre P., Borland J., et al. Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects. J Acquir Immune Defic Syndr: 2013; 62 1 21 27
65. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services. Available at: http://aidsinfo.nih. gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed September 15, 2013
66. Abdool Karim S. S., Naidoo K., Grobler A., et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med: 2011; 365 16 1492 1501
67. Blanc F. X., Sok T., Laureillard D., et al. CAMELIA (ANRS 1295-CIPRA KH001) Study Team. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med: 2011; 365 16 1471 1481
68. Havlir D. V., Kendall M. A., Ive P., et al. AIDS Clinical Trials Group Study A5221. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med: 2011; 365 16 1482 1491
69. Török M. E., Yen N. T., Chau T. T., et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)-Associated tuberculous meningitis. Clin Infect Dis: 2011; 52 11 1374 1383
70. Marais S., Meintjes G., Pepper D. J., et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis: 2013; 56 3 450 460
71. El Sahly H. M., Teeter L. D., Pan X., Musser J. M., Graviss E. A. Mortality associated with central nervous system tuberculosis. J Infect: 2007; 55 6 502 509 (Pubitemid 350082470)
72. Tho D. Q., Török M. E., Yen N. T., et al. Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-Associated tuberculous meningitis. Antimicrob Agents Chemother: 2012; 56 6 3074 3079
73. Luma H. N., Tchaleu B. C., Ngahane B. H., et al. Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study. AIDS Res Ther: 2013; 10 1 16
74. Pepper D. J., Marais S., Maartens G., et al. Neurologic manifestations of paradoxical tuberculosis-Associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis: 2009; 48 11 e96 e107
75. Middelkoop K., Bekker L. G., Myer L., et al. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med: 2010; 182 8 1080 1085
76. Thwaites G. E., van Toorn R., Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol: 2013; 12 10 999 1010
77. Thwaites G. E., Chau T. T., Stepniewska K., et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet: 2002; 360 9342 1287 1292 (Pubitemid 35284620)
78. Ho J., Marais B. J., Gilbert G. L., Ralph A. P. Diagnosing tuberculous meningitis - have we made any progress? Trop Med Int Health: 2013; 18 6 783 793
79. Patel V. B., Theron G., Lenders L., et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med: 2013; 10 10 e1001536
80. Darras-Joly C., Chevret S., Wolff M., et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis: 1996; 23 2 369 376 (Pubitemid 26264921)
81. Rozenbaum R., Gonçalves A. J. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis: 1994; 18 3 369 380 (Pubitemid 24086307)
82. Asawavichienjinda T., Sitthi-Amorn C., Tanyanont V. Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis. J Med Assoc Thai: 1999; 82 1 65 71
83. McNeil M. M., Ampel N. M. Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis: 1995; 21 01 S111 S113
84. Masannat F. Y., Ampel N. M. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis: 2010; 50 1 1 7
85. Johnson R. H., Einstein H. E. Coccidioidal meningitis. Clin Infect Dis: 2006; 42 1 103 107 (Pubitemid 41832088)
86. Wheat L. J., Connolly-Stringfield P. A., Baker R. L., et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore): 1990; 69 6 361 374 (Pubitemid 20386532)
87. Hage C. A., Ribes J. A., Wengenack N. L., et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis: 2011; 53 5 448 454
88. Pappas P. G., Pottage J. C., Powderly W. G., et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med: 1992; 116 10 847 853 (Pubitemid 23034764)
89. Bariola J. R., Perry P., Pappas P. G., et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis: 2010; 50 6 797 804
90. Durkin M., Witt J., Lemonte A., Wheat B., Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol: 2004; 42 10 4873 4875 (Pubitemid 39362430)
91. Zetola N. M., Klausner J. D. Syphilis and HIV infection: an update. Clin Infect Dis: 2007; 44 9 1222 1228 (Pubitemid 46651249)
92. Marra C. M., Maxwell C. L., Tantalo L., et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis: 2004; 38 7 1001 1006 (Pubitemid 38457209)
93. Corey L., Adams H. G., Brown Z. A., Holmes K. K. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med: 1983; 98 6 958 972 (Pubitemid 13053413)
94. Smith A. B., Smirniotopoulos J. G., Rushing E. J. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics: 2008; 28 7 2033 2058
95. Tan I. L., Smith B. R., von Geldern G., Mateen F. J., McArthur J. C. HIV-Associated opportunistic infections of the CNS. Lancet Neurol: 2012; 11 7 605 617
96. Bylsma S. S., Achim C. L., Wiley C. A., et al. The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Arch Ophthalmol: 1995; 113 1 89 95
97. Guven T., Ugurlu K., Ergonul O., et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis: 2013; 56 10 1407 1412
98. Al-Sous M. W., Bohlega S., Al-Kawi M. Z., Alwatban J., McLean D. R. Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol: 2004; 25 3 395 401 (Pubitemid 38374917)
99. Clarke J. L., Perez H. R., Jacks L. M., Panageas K. S., Deangelis L. M. Leptomeningeal metastases in the MRI era. Neurology: 2010; 74 18 1449 1454
100. Bernaerts A., Vanhoenacker F. M., Parizel P. M., et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol: 2003; 13 8 1876 1890 (Pubitemid 36949714)
101. Gupta R. K., Vatsal D. K., Husain N., et al. Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol: 2001; 22 8 1503 1509 (Pubitemid 32862261)
102. Tan I. L., Smith B. R., von Geldern G., Mateen F. J., McArthur J. C. HIV-Associated opportunistic infections of the CNS. Lancet Neurol: 2012; 11 7 605 617
103. Thwaites G. E., van Toorn R., Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol: 2013; 12 10 999 1010
104. Smith A. B., Smirniotopoulos J. G., Rushing E. J. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics: 2008; 28 7 2033 2058
105. Antinori A., Larussa D., Cingolani A., et al. Italian Registry Investigative NeuroAIDS. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis: 2004; 39 11 1681 1691 (Pubitemid 39578546)
106. Kupfer M. C., Zee C. S., Colletti P. M., Boswell W. D., Rhodes R. MRI evaluation of AIDS-related encephalopathy: toxoplasmosis vs. lymphoma. Magn Reson Imaging: 1990; 8 1 51 57 (Pubitemid 20175240)
107. Porter S. B., Sande M. A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med: 1992; 327 23 1643 1648
108. Thurnher M. M., Thurnher S. A., Schindler E. CNS involvement in AIDS: spectrum of CT and MR findings. Eur Radiol: 1997; 7 7 1091 1097 (Pubitemid 127537138)
109. Jenkins C. N., Colquhoun I. R. Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification haemorrhage and cyst formation. Clin Radiol: 1998; 53 6 428 434 (Pubitemid 28282598)
110. Forsyth P. A., DeAngelis L. M. Biology and management of AIDS-Associated primary CNS lymphomas. Hematol Oncol Clin North Am: 1996; 10 5 1125 1134 (Pubitemid 26314138)
111. Rozenbaum R., Gonçalves A. J. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis: 1994; 18 3 369 380 (Pubitemid 24086307)
112. Perfect J. R., Dismukes W. E., Dromer F., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis: 2010; 50 3 291 322
113. Tan K., Roda R., Ostrow L., McArthur J., Nath A. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology: 2009; 72 17 1458 1464
114. Weissert R. Progressive multifocal leukoencephalopathy. J Neuroimmunol: 2011; 231 1-2 73 77
115. Cordova E., Boschi A., Ambrosioni J., Cudos C., Corti M. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis: 2008; 12 6 587 592
116. Diazgranados C. A., Saavedra-Trujillo C. H., Mantilla M., Valderrama S. L., Alquichire C., Franco-Paredes C. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis: 2009; 9 5 324 330